EXTON, Pa., May 2, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma,

Workforce Development and Deployment: MSC's simulation-based programs provided standardized training that has demonstrated the ability to improve health care professionals' knowledge and confidence in evidence-based guidelines for patient care. Speed to Implementation: MSC's programs and turnkey training services are current with national guidelines and immediately available for rapid deployment across an entire health care organization. Model Sustainability

EINDHOVEN, The Netherlands, October 3, 2011 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM), the Netherlands' Top Institute for research in molecular

PRINCETON, N.J., Sept.

EXTON, Pa., June 2, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the Jefferies 2011 Global Healthcare Conference at 2:00 P.M. ET on Wednesday, June 8, 2011.